Application Of Commercial Enteral Nutrition In Patients With Stroke Dysphagia In NICU

Objectives:The nutritional status of stroke inpatients with dysphagia in NICU in Department of Neurology,China-Japan Friendship Hospital of Jilin University was comprehensively understood by nutritional assessment.Different commercialized enteral nutrition preparations were used for nutritional support,and the effects of commercialized enteral nutrition preparations on patients’ biochemical detection indexes,physical monitoring indexes,complications and nutritional support expenses of patients were analyzed.Methods:1.Subjects: Patients with stroke hospitalized in the NICU Department of Neurology,China-Japan Friendship Hospital of Jilin University from December 2018 to December 2020 were selected to determine whether the above-mentioned patients had dysphagia through the drinking water test in the depression field,and the patients with dysphagia were selected as the research objects.Finally,315 stroke dysphagia inpatients in the NICU who met the inclusion criteria were included in this study.2.Grouping and intervention methods: According to the NICU inpatients with stroke dysphagia were given different commercial enteral nutrition formulations,and the biochemical monitoring indexes,physical monitoring indexes,complications and nutritional support costs of the patients in different groups were compared.3.Biochemical test indexes: routine venous fasting blood was extracted from patients on the next day after admission,and biochemical test indexes such as total protein(TP),prealbumin(PA),and Albumin(ALB)were monitored.4.Physical monitoring indicators: the height and weight of the patients were measured,and the body MSAA index(BMI)of the patients was calculated according to the height and weight.5.Complications: common complications after admission.6.The cost of nutritional support: Take standard patients as an example,the cost of nutritional support required by patients in one day.Results:1.Basic information of enrolled patients: A total of 315 patients,aged65.45±11.62 years old,were included,including 300 patients over 45 years old(95.20%)and 15 patients under 45 years old(4.80%).There were 200 males(63.50%)with an average age of 64.10±12.59 years.There were 115 females(36.50%)with an average age of 67.81±9.29 years.2.Clinical data at admission:(1)There were 280 cases of middle cerebral infarction(88.90%),29 cases of cerebral hemorrhage(9.20%),and 6 cases of subarachnoid hemorrhage(1.90%).There were 192 cases of first stroke,accounting for 60.90% of the total.202 patients with hypertension,accounting for 64.10% of the total number of cases in this study;104 patients(33.00%)had a history of diabetes.87patients(27.60%)had a history of heart disease and atrial fibrillation.29 patients with hypoproteinemia at admission,accounting for 9.20%;There were 29 patients with anemia at admission,accounting for 9.20%.(2)There were 48 cases of mild stroke,accounting for 15.20%;There were 204 cases of moderate,moderate to severe stroke,accounting for 64.80%;Severe stroke occurred in 63 patients(20.00%).3.(1)Application of commercial enteral nutrition in patients with stroke dysphagia in NICU:(1)30 patients were treated with the general type of vitamin integrin nutrition,23 males(77.00%)and 7 females(23.00%).(2)77 cases of high energy and high protein type were applied,including 37 males(48.10%)and 40females(51.90%).(3)There were 26 cases of Venerable short peptide,of which 20 were males(76.90%)and 6 were females(23.10%).(4)Thirty-one patients were treated with Junbeijia,including 20 males(64.50%)and 10 females(35.50%).(5)61 cases of Weiyuan(whole nutrition formula food)were used,among which 46 cases were male,accounting for 75.40%,and 15 cases were female,accounting for 24.60%.(6)31 cases were treated with Junbeiyuankang(high protein,low potassium,low sodium total nutrition),16 cases were male,accounting for 51.60%,15 cases were female,accounting for 48.40%.(7)In 41 cases of Vicanerol IG,28 cases(68.30%)were male and 13 cases(21.70%)were female.(8)Twenty-four patients were treated with Vicanen whey protein,17 males(70.80%)and 24 females(29.20%).(2)Comparison of nutrition-related laboratory indicators and complications: the data of different commercial enteral nutrition preparations showed that there was no difference in body weight,BMI,and biochemical indicators of TP,PA and HGB among patients in different groups.(3)Cost comparison: there were differences in nutritional support costs among patients in different groups.Conclusion:1.Commercialized enteral nutrition preparations are suitable for nutritional support of patients with stroke and dysphagia.2.Patients with different commercial enteral nutrition preparations may have different physical test indexes and biochemical test indexes,and complications may occur in all patients.3.According to the characteristics of patients’ diseases and enteral nutrition products,individualized commercial enteral nutrition preparations that are more suitable for patients’ nutritional support should be selected.